High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial

R.S Hermanides; A.A.C.M. Heestermans; J.M. ten Berg; A.T.M. Gosselink; J.P. Ottervanger; K.G. van Houwelingen; J.J.E. Kolkman; P.R. Stella; T. Dill; C. Hamm; A.W.J. van het Hof

doi:10.1136/hrt.2010.194951

High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial

R.S Hermanides, A.A.C.M. Heestermans, J.M. ten Berg, A.T.M. Gosselink, J.P. Ottervanger, K.G. van Houwelingen, J.J.E. Kolkman, P.R. Stella, T. Dill, C. Hamm, A.W.J. van het Hof

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	106-111
Number of pages	6
Journal	Heart
Volume	97
Issue number	2
DOIs	https://doi.org/10.1136/hrt.2010.194951
Publication status	Published - 2011

Access to Document

10.1136/hrt.2010.194951

Cite this

Hermanides, R. S., Heestermans, A. A. C. M., ten Berg, J. M., Gosselink, A. T. M., Ottervanger, J. P., van Houwelingen, K. G., Kolkman, J. J. E., Stella, P. R., Dill, T., Hamm, C., & van het Hof, A. W. J. (2011). High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial. Heart, 97(2), 106-111. https://doi.org/10.1136/hrt.2010.194951

@article{6e4f0066b0614340b3217a505697b732,

title = "High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial",

author = "R.S Hermanides and A.A.C.M. Heestermans and {ten Berg}, J.M. and A.T.M. Gosselink and J.P. Ottervanger and {van Houwelingen}, K.G. and J.J.E. Kolkman and P.R. Stella and T. Dill and C. Hamm and {van het Hof}, A.W.J.",

year = "2011",

doi = "10.1136/hrt.2010.194951",

language = "English",

volume = "97",

pages = "106--111",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

number = "2",

}

Hermanides, RS, Heestermans, AACM, ten Berg, JM, Gosselink, ATM, Ottervanger, JP, van Houwelingen, KG, Kolkman, JJE, Stella, PR, Dill, T, Hamm, C & van het Hof, AWJ 2011, 'High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial', Heart, vol. 97, no. 2, pp. 106-111. https://doi.org/10.1136/hrt.2010.194951

High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial. / Hermanides, R.S; Heestermans, A.A.C.M.; ten Berg, J.M. et al.
In: Heart, Vol. 97, No. 2, 2011, p. 106-111.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial

AU - Hermanides, R.S

AU - Heestermans, A.A.C.M.

AU - ten Berg, J.M.

AU - Gosselink, A.T.M.

AU - Ottervanger, J.P.

AU - van Houwelingen, K.G.

AU - Kolkman, J.J.E.

AU - Stella, P.R.

AU - Dill, T.

AU - Hamm, C.

AU - van het Hof, A.W.J.

PY - 2011

Y1 - 2011

U2 - 10.1136/hrt.2010.194951

DO - 10.1136/hrt.2010.194951

M3 - Article

C2 - 20962338

SN - 1355-6037

VL - 97

SP - 106

EP - 111

JO - Heart

JF - Heart

IS - 2

ER -